Activation of protease‑activated receptor‑2 is associated with increased expression of inflammatory factors in the adipose tissues of obese mice

Li,Mengmeng; Yang,Xiaoming; Zhang,Yadong; Chen,Liang; Lu,Hanyu; Li,Xiaobo; Yin,Lianhua; Zhi,Xiuling

doi:10.3892/mmr.2015.4179

Activation of protease‑activated receptor‑2 is associated with increased expression of inflammatory factors in the adipose tissues of obese mice

Authors:
- Mengmeng Li
- Xiaoming Yang
- Yadong Zhang
- Liang Chen
- Hanyu Lu
- Xiaobo Li
- Lianhua Yin
- Xiuling Zhi
View Affiliations

Affiliations: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, P.R. China, Department of Pathophysiology, School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China, Laboratory of Molecular Biology, Training Center of Medical Experiments, School of Basic Medical Sciences, Fudan University, Shanghai 200032, P.R. China
Published online on: August 5, 2015 https://doi.org/10.3892/mmr.2015.4179
Pages: 6227-6234

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Previous studies have indicated that mast cells are critical for the pathogenesis of inflammatory diseases. Proteases released from mast cells have been reported to stimulate protease‑activated receptors (PAR), which induces microleakage and widespread inflammation. In order to investigate the pro‑inflammatory effect of PAR‑2 activation on adipose inflammation in obese mice, the varying distributions of macrophages and PAR‑2 in adipose tissue samples were compared between C57BL/6J (C57) and obese mice [B6(D)‑Leprdb/J, BKS(D)‑Leprdb/J and B6.V‑Lepob/J (ob/ob)] using immunohistochemical staining. Murine primary adipocytes and bone marrow‑derived macrophages (BMDMs) were used and the alterations in expression levels of inflammatory factors, induced by PAR‑2 activation, were detected by reverse transcription‑quantitative polymerase chain reaction and ELISA. In addition, the migratory capacity of primary BMDMs and the macrophage cell line, RAW264.7 were evaluated by co‑culture with primary adipocytes. The current study demonstrated a larger number of macrophages in the adipose tissues of obese mice compared with C57 mice. Furthermore, PAR‑2 expression was detected in various adipose tissues of mice and the protein expression levels of PAR‑2 were observed to be significantly higher in the total adipose tissues of ob/ob mice when compared with the C57 mice. The expression levels of inflammatory factors were increased in adipocytes and macrophages, and enhanced migratory ability was observed in macrophages pretreated with PAR‑2 agonists. The data of the current study suggests that PAR‑2 is involved in the process of obesity‑associated chronic low‑grade systemic inflammation, which indicates that the PAR‑2 signaling pathway may be a potential target for the treatment of obesity and its associated diseases.

View Figures

View References

1	Trayhurn P: Endocrine and signalling role of adipose tissue: New perspectives on fat. Acta Physiol Scand. 184:285–293. 2005. View Article : Google Scholar : PubMed/NCBI
2	Lasselin J and Capuron L: Chronic low-grade inflammation in metabolic disorders: Relevance for behavioral symptoms. Neuroimmunomodulation. 21:95–101. 2014.PubMed/NCBI
3	Martinez-Santibañez G and Lumeng CN: Macrophages and the regulation of adipose tissue remodeling. Annu Rev Nutr. 34:57–76. 2014. View Article : Google Scholar
4	Cottam DR, Mattar SG, Barinas-Mitchell E, Eid G, Kuller L, Kelley DE and Schauer PR: The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: Implications and effects of weight loss. Obes Surg. 14:589–600. 2004. View Article : Google Scholar : PubMed/NCBI
5	Altintas MM, Rossetti MA, Nayer B, Puig A, Zagallo P, Ortega LM, Johnson KB, McNamara G, Reiser J, Mendez AJ and Nayer A: Apoptosis, mastocytosis and diminished adipocytokine gene expression accompany reduced epididymal fat mass in long-standing diet-induced obese mice. Lipids Health Dis. 10:1982011. View Article : Google Scholar
6	Liu J, Divoux A, Sun J, et al: Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med. 15:940–945. 2009. View Article : Google Scholar : PubMed/NCBI
7	Lim J, Iyer A, Liu L, Suen JY, Lohman RJ, Seow V, Yau MK, Brown L and Fairlie DP: Diet-induced obesity, adipose inflammation, and metabolic dysfunction correlating with PAR2 expression are attenuated by PAR2 antagonism. FASEB J. 27:4757–4767. 2013. View Article : Google Scholar : PubMed/NCBI
8	Rothmeier AS and Ruf W: Protease-activated receptor 2 signaling in inflammation. Semin Immunopathol. 34:133–149. 2012. View Article : Google Scholar
9	Lu J, Chen B, Li S and Sun Q: Tryptase inhibitor APC 366 prevents hepatic fibrosis by inhibiting collagen synthesis induced by tryptase/protease-activated receptor 2 interactions in hepatic stellate cells. Int Immunopharmacol. 20:352–357. 2014. View Article : Google Scholar : PubMed/NCBI
10	Lu C, Zhao FD, Li XB and Yin LH: Up regulation of interleukin-8 expressions induced by mast cell tryptase via protease activated receptor-2 in endothelial cell line. Chin Med J (Engl). 118:1900–1906. 2005.
11	Ma Y, Zhang B, Qian R, Lu C, Zhao F and Yin L: Tryptase activates PKB in inflammatory reaction in ECV304 cells. Biochim Biophys Acta. 1763:313–321. 2006. View Article : Google Scholar : PubMed/NCBI
12	Jiang YF, Zhao FD, Li XB, Ning YX, Zhi XL, Qian RZ and Yin LH: Effects of RNA interference-induced tryptase down-regulation in P815 cells on IL-6 and TNF-alpha release of endothelial cells. J Zhejiang Univ Sci B. 9:656–661. 2008. View Article : Google Scholar : PubMed/NCBI
13	Ilich JZ, Kelly OJ, Kim Y and Spicer MT: Low-grade chronic inflammation perpetuated by modern diet as a promoter of obesity and osteoporosis. Arh Hig Rada Toksikol. 65:139–148. 2014. View Article : Google Scholar : PubMed/NCBI
14	Adamczak M and Wiecek A: The adipose tissue as an endocrine organ. Semin Nephrol. 33:2–13. 2013. View Article : Google Scholar : PubMed/NCBI
15	Ouchi N, Parker JL, Lugus JJ and Walsh K: Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 11:85–97. 2011. View Article : Google Scholar : PubMed/NCBI
16	Gustafson B and Smith U: Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3-L1 preadipocytes. J Biol Chem. 281:9507–9516. 2006. View Article : Google Scholar : PubMed/NCBI
17	Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, Hofmann SM, Schraw T, Durand JL, Li H, Li G, et al: Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest. 117:2621–2637. 2007. View Article : Google Scholar : PubMed/NCBI
18	Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL and Ferrante AW Jr: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 112:1796–1808. 2003. View Article : Google Scholar : PubMed/NCBI
19	Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA and Chen H: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 112:1821–1830. 2003. View Article : Google Scholar : PubMed/NCBI
20	Lumeng CN, Bodzin JL and Saltiel AR: Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 117:175–184. 2007. View Article : Google Scholar : PubMed/NCBI
21	Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A and Locati M: The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25:677–686. 2004. View Article : Google Scholar : PubMed/NCBI
22	Theoharides TC, Alysandratos KD, Angelidou A, Delivanis DA, Sismanopoulos N, Zhang B, Asadi S, Vasiadi M, Weng Z, Miniati A and Kalogeromitros D: Mast cells and inflammation. Biochim Biophys Acta. 1822:21–33. 2012. View Article : Google Scholar :
23	Schmidlin F and Bunnett NW: Protease-activated receptors: How proteases signal to cells. Curr Opin Pharmacol. 1:575–582. 2001. View Article : Google Scholar
24	Ossovskaya VS and Bunnett NW: Protease-activated receptors: Contribution to physiology and disease. Physiol Rev. 84:579–621. 2004. View Article : Google Scholar : PubMed/NCBI
25	Lewkowich IP, Day SB, Ledford JR, Zhou P, Dienger K, Wills-Karp M and Page K: Protease-activated receptor 2 activation of myeloid dendritic cells regulates allergic airway inflammation. Respir Res. 12:1222011. View Article : Google Scholar : PubMed/NCBI
26	Lindner JR, Kahn ML, Coughlin SR, Sambrano GR, Schauble E, Bernstein D, Foy D, Hafezi-Moghadam A and Ley K: Delayed onset of inflammation in protease-activated receptor-2-deficient mice. J Immunol. 165:6504–6510. 2000. View Article : Google Scholar : PubMed/NCBI
27	Mamatzunun M, Ma YJ, Lu C, Zhao FD and Yin LH: Effect of tryptase on the expression of IL-6 and TNF-α in microvascular endothelial cell. Fudan Univ J Med Sci. 33:217–221. 2006.
28	Badeanlou L, Furlan-Freguia C, Yang G, Ruf W and Samad F: Tissue factor-protease-activated receptor 2 signaling promotes diet-induced obesity and adipose inflammation. Nat Med. 17:1490–1497. 2011. View Article : Google Scholar : PubMed/NCBI
29	Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R, Kitazawa S, Miyachi H, Maeda S, Egashira K and Kasuga M: MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance and hepatic steatosis in obesity. J Clin Invest. 116:1494–1505. 2006. View Article : Google Scholar : PubMed/NCBI